At a glance
ClinicalIndex Comparison RecordN/ACompleted· 286 enrolled
Drug / intervention
No interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid Arthritis
In Brief
An observational study evaluating No intervention for Dry Eye Syndromes and Rheumatoid Arthritis. Completed, enrolled 286 participants.
Detailed Summary
This study will evaluate the prevalence of dry eye disease in patients diagnosed with rheumatoid arthritis. No treatment is administered in this study.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndromes, Rheumatoid Arthritis
Countries--
CollaboratorsAllergan
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2012
Primary CompletionJun 2014
First PostedSep 2014
Study CompletionDec 2014
TodayJul 2026
First PostedSep 30, 2014
Enrollment StartNov 1, 2012
Primary CompletionJun 1, 2014
Study CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 11.8 years ago
Interventions
No interventionother